GRI Bio, Inc.
GRI • XNAS
GRI Bio, Inc. is a biotechnology company in the healthcare sector trading on XNAS, led by CEO W. Marc Hertz, with a market cap of $3.4M.
Market Cap$3.4M
CEOW. Marc Hertz
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 14, 2026 · in a monthQ1 2026
Financials
GRI Bio, Inc. FAQ
Common questions about GRI Bio, Inc.
GRI Bio, Inc. is scheduled to report earnings for Q1 2026 on May 14, 2026.